U.S. market Closed. Opens in 11 hours 35 minutes

UTMD | Utah Medical Products, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for UTMD we got that it has average fundamentals where Valuation is considered to be undervalued, Profitability is very wealthy, Growth is desperately bad and Health is confidently strong.

Valuation (76%)

Company Industry
P/E Ratio (TTM) 15.75 51.65
PEG Ratio (TTM) 7.10 3.84
P/S Ratio (TTM) 5.08 12.48
P/B Ratio (TTM) 1.98 6.59
P/FCF Ratio (TTM) 13.08 328.37
Price to 5YR AVG Earnings Ratio 16.94 113.80
Price to 5YR AVG FCF Ratio 15.28 86.86

Profitability (75%)

Company Industry
ROA (TTM) 12.02% 6.88%
ROE (TTM) 12.41% 12.83%
Net Profit Margin (TTM) 33.56% 2.60%
ROIC 5YR AVG 28.99% 11.03%

Growth (20%)

4QTR AVG 3YR AVG 5YR AVG
EPS -4.53% -2.85% 0.88%
Revenue -5.13% 5.97% 4.11%
Net Income -4.45% -3.45% 0.41%
Cash Flow -10.09% 8.23% 5.96%

Health (89%)

Company Industry
Current Ratio (TTM) 25.98 3.37
Quick Ratio (TTM) 23.68 2.56
D/E Ratio (TTM) 0.00 0.39
Interest Coverage (TTM) 8.64 28.02
Piotroski F-Score 7 6
Altman Z-Score 26.98 22.94
LTL to 5YR AVG FCF 0.02 4.38
Shares Outstanding Growth 5YR AVG -0.55% 2.71%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙